1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015

Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hand, Foot And Mouth Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Hand, Foot And Mouth Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Figures 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Middle East and Africa 9
Clinical Trials by E7 Countries: Proportion of Hand, Foot And Mouth Disease to Infectious Disease Clinical Trials 10
Clinical Trials in E7 Countries by Trial Status 11
Clinical Trials by Phase 12
In Progress Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Subjects Recruited Over a Period of Time 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in Hand, Foot And Mouth Disease Therapeutics Clinical Trials 19
Prominent Drugs 21
Clinical Trial Profile Snapshots 22
Appendix 37
Abbreviations 37
Definitions 37
Research Methodology 38
Secondary Research 38
About GlobalData 39
Contact Us 39
Disclaimer 39
Source 40

List of Figures
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Region, 2015* 5
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 9
Proportion of Hand, Foot And Mouth Disease to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 10
Hand, Foot And Mouth Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 11
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 12
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 13
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 16
Hand, Foot And Mouth Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 17
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 18
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 20
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 21

List of Figures
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8
Proportion of Hand, Foot And Mouth Disease to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 10
Hand, Foot And Mouth Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 11
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 12
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 13
Hand, Foot And Mouth Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 14
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 15
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 16
Hand, Foot And Mouth Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 17
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 18
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 19
Hand, Foot And Mouth Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 21
GlobalData Methodology 38

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Periodontal Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Gingivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Global Animal Health Partnering Terms and Agreements 2010 to 2016

Global Animal Health Partnering Terms and Agreements 2010 to 2016

  • $ 1995
  • Industry report
  • October 2016
  • by Currentpartnering

Welcome to the Global Animal Health Partnering Terms and Agreements 2010 to 2016 report. The report provides a detailed understanding and analysis of how and why companies enter Animal Health partnering ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.